Screener
Immix Biopharma, Inc. IMMX Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001493152-26-021764
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies | - | - |
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding | - | |
| Common stock, $0.0001 par value; 200,000,000 shares authorized; 53,084,455 shares issued and 53,012,092 shares outstanding at March 31, 2026 and 53,023,466 shares issued and 52,951,103 shares outstanding at December 31, 2025 | 5,307 | 5,301 |
| Additional paid-in capital | 198,903,047 | 198,293,956 |
| Accumulated other comprehensive income | 105,636 | 60,160 |
| Accumulated deficit | (114,549,971) | (104,463,284) |
| Treasury stock at cost, 72,363 shares as of March 31, 2026 and December 31, 2025 | (99,963) | (99,963) |
Document
FAQ
- What is Immix Biopharma, Inc.'s common stock?
- Immix Biopharma, Inc. (IMMX) reported common stock of 200M in Q1 2026.
- How has Immix Biopharma, Inc.'s common stock changed year-over-year?
- Immix Biopharma, Inc.'s common stock decreased by 0.0% year-over-year, from 200M to 200M.
- What is the long-term trend for Immix Biopharma, Inc.'s common stock?
- Over 5 years (2020 to 2025), Immix Biopharma, Inc.'s common stock has grown at a 58.5% compound annual growth rate (CAGR), from 20M to 200M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Immix Biopharma, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude